Can a Big Pharma Ever Be Worth $1 Trillion?

There are five tech companies valued at over $1 trillion. In healthcare, the closest contender is…

Obesity Drugs Put These Stocks on a Crash Diet—Now They’re Rebounding

There is a bit of cognitive dissonance in healthcare investing right now. After reviewing the highly…

The Trouble With America’s Ultra-Processed Diet

Listen to article (2 minutes) Should your granola bar come with a warning label? Concern is…

New Breed of Supercomputer Aims for the Two Quintillion Mark

That’s two billion billion operations a second, enough to explore the brain and discover drugs.

Opinion | Biden’s Race Against a Cure

Updated Nov. 13, 2023 7:27 pm ET The Food and Drug Administration may soon approve two…

Wegovy Maker Novo Nordisk to Spend $6 Billion Boosting Production Capacity

Novo Nordisk, the Danish pharmaceutical giant that makes the blockbuster Wegovy obesity drug, said it will…

How to Outsmart the Time Change

Listen to article (2 minutes) Americans in most states will turn their clocks back one hour…

Obesity Drug Demand Outstrips Supply

Eli Lilly’s blockbuster diabetes medication Mounjaro is expected to receive Food and Drug Administration approval as…

Never Mind Covid, Investors Want a Pfizer Obesity Pill

Some of this year’s best performers in the healthcare sector are companies expected to profit from…

Stacking Boxes? Treating Cancer? AI Needs to Learn Physics First

Artificial intelligence has dazzled the world in the past year, largely because of large language models…